NRC HEALTH
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M |
| Selling, general & administrative | $54.8M | $44.9M | $46.6M | $42.7M | $39.0M |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M |
| Interest expense | $4.8M | $2.6M | $862,000 | $1.2M | $1.7M |
| Pretax income | $17.8M | $32.7M | $40.0M | $42.8M | $48.6M |
| Income tax expense | $6.2M | $7.9M | $9.0M | $11.0M | $11.2M |
| Net income | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M |
| Balance Sheet | |||||
| Cash and equivalents | $4.1M | $4.2M | $6.7M | $25.0M | $54.4M |
| Current assets | $20.2M | $19.6M | $24.4M | $43.7M | $73.7M |
| Total assets | $134.9M | $132.5M | $122.4M | $130.5M | $157.5M |
| Current liabilities | $36.6M | $35.9M | $36.2M | $33.4M | $40.4M |
| Total liabilities | $120.9M | $101.3M | $73.5M | $58.4M | $72.2M |
| Stockholders' equity | $14.0M | $31.3M | $49.0M | $72.0M | $85.3M |
| Cash Flow Statement | |||||
| Cash from operations | $26.4M | $34.6M | $38.1M | $36.3M | $46.3M |
| Depreciation and amortization | $7.6M | $6.0M | $5.9M | — | — |
| Stock-based compensation | $3.3M | $284,000 | $935,000 | $1.2M | $623,000 |
| Capital expenditure | $10.7M | $15.4M | $15.8M | $9.8M | $5.5M |
| Free cash flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M |
| Dividends paid | $11.0M | $11.5M | $36.4M | $21.0M | $9.2M |
| Share repurchases | $20.2M | $30.9M | $19.1M | $27.6M | $4.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 22.5M · Free float 12.2%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.